Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01644513 · ClinicalTrials.gov registry record
Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients
A clinical trial, sponsored by Sequenom.
- Completed
- Registry status
- 196
- Enrollment target
NCT01644513 is a clinical trial that has completed, run by Sequenom. The registered enrollment target is 196 participants.
The verdict
NCT01644513 has completed, sponsored by Sequenom.
- COMPLETED
- Registry status
- 196 participants
- Enrollment target
Study Summary
Patients with AMD who are being or have been treated with eye injections of drugs known as anti-VEGF agents with either good or poor response will have DNA collected with check swabs for analysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2012-07 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01644513
The ClinicalTrials.gov registry entry for NCT01644513 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sequenom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01644513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01644513 about?
NCT01644513 is a clinical study titled "Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients". Patients with AMD who are being or have been treated with eye injections of drugs known as anti-VEGF agents with either good or poor response will have DNA collected with check swabs for analysis.
What is the current status of trial NCT01644513?
This trial is currently completed. The enrollment target is 196 participants. The study started on 2012-07. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01644513?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.